Markets:

Overview

News

Currencies

International

Treasuries

Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

4.250 +0.090 (+2.16%)

Delayed Quote Updated: 10:29 AM EST, Nov 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 4 Next >

What Nuvation Bio (NUVB) Said on Its Q3 Earnings Call ↗

November 08, 2026

Nuvation Bio (NYSE:NUVB) reported $45 million in third-quarter 2026 revenue as U.S. sales of lung cancer treatment IBTROZI rose 18% from the previous quarter, even as the company said new patient...

Via MarketBeat

Topics Earnings

Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript ↗

November 05, 2026

Management weighed a European milestone and new glioma data ahead of 2027.

Via The Motley Fool

Topics Earnings

Nuvation Bio (NYSE:NUVB) Posts Revenue Beat as IBTROZI Momentum Faces After-Hours Pullback ↗

November 04, 2026

Via Chartmill

Nuvation Bio (NUVB) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

IBTROZI revenue hit $23.2 million with 85% of new patient starts in first-line setting.

Via The Motley Fool

Topics Earnings

Nuvation Bio (NYSE:NUVB) Soars 22% After Earnings Beat Fueled by Strong Lung Cancer Drug Launch ↗

May 04, 2026

Via Chartmill

Topics Earnings

NUVATION BIO INC (NYSE:NUVB) Stock Plunges 9% After Q4 Earnings Reveal Revenue Beat but Wider Loss ↗

March 02, 2026

Via Chartmill

Nuvation Bio Q2 Earnings Call Highlights ↗

August 08, 2026

Nuvation Bio (NYSE:NUVB) reported second-quarter total revenue of $31.7 million, including $23.2 million in net U.S. product revenue from IBTROZI, as the company said use of the ROS1-targeted lung...

Via MarketBeat

Topics Earnings

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale? ↗

June 29, 2026

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Via The Motley Fool

Topics Regulatory Compliance

Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum ↗

June 17, 2026

Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains.

Via The Motley Fool

Topics Regulatory Compliance

Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut ↗

November 20, 2025

Via Stocktwits

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

4 Analysts Assess Nuvation Bio: What You Need To Know ↗

September 30, 2025

Via Benzinga

Analyst Expectations For Nuvation Bio's Future ↗

September 08, 2025

Via Benzinga

Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗

May 15, 2026

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions.

Via The Motley Fool

Topics Regulatory Compliance

Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗

May 15, 2026

Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors.

Via The Motley Fool

Topics Regulatory Compliance

Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗

May 15, 2026

Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.

Via The Motley Fool

Topics Regulatory Compliance

Nuvation Bio (NUVB) Q1 2026 Earnings Transcript ↗

May 04, 2026

Nuvation Bio (NUVB) Q1 2026 Earnings Transcript

Via The Motley Fool

Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) ↗

April 13, 2026

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent filings.

Via The Motley Fool

Topics Regulatory Compliance

SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction ↗

March 03, 2026

SSR Mining runs a diversified portfolio of gold, silver, and base metal mines across four continents with a vertically integrated model.

Via The Motley Fool

Topics ETFs Regulatory Compliance

Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy ↗

March 03, 2026

This clinical-stage biotech advances oncology therapies with a pipeline of novel small molecule inhibitors for hard-to-treat cancers.

Via The Motley Fool

Topics Regulatory Compliance

Which stocks are gapping on Tuesday? ↗

March 03, 2026

Via Chartmill

Nuvation Bio (NUVB) Q4 2025 Earnings Transcript ↗

March 03, 2026

Nuvation Bio (NUVB) Q4 2025 Earnings Transcript

Via The Motley Fool

Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance

November 19, 2025

Boston, MA – November 19, 2025 – Nuvation Bio Inc. (NASDAQ: NUVB) has captured the financial spotlight, witnessing a remarkable 47.71% surge in its stock price following a stellar third-quarter 2025...

Via MarketMinute

Which stocks are moving on Wednesday? ↗

November 19, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 19, 2025

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 19, 2025

Via Benzinga

Nuvation Bio (NUVB) Q3 2025 Earnings Transcript ↗

November 04, 2025

Nuvation Bio (NUVB) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings

Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock ↗

November 03, 2025

Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock

Via The Motley Fool

Topics Regulatory Compliance

Why Nuvation Bio Stock Is Skyrocketing Today ↗

September 30, 2025

The bulls are lining up on Wall Street for this up-and-coming biotech stock.

Via The Motley Fool

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗

September 30, 2025

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.